325 related articles for article (PubMed ID: 32869366)
1. Matrix metalloproteinases in keratinocyte carcinomas.
Riihilä P; Nissinen L; Kähäri VM
Exp Dermatol; 2021 Jan; 30(1):50-61. PubMed ID: 32869366
[TBL] [Abstract][Full Text] [Related]
2. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer.
Kerkelä E; Saarialho-Kere U
Exp Dermatol; 2003 Apr; 12(2):109-25. PubMed ID: 12702139
[TBL] [Abstract][Full Text] [Related]
4. Sun protection for preventing basal cell and squamous cell skin cancers.
Sánchez G; Nova J; Rodriguez-Hernandez AE; Medina RD; Solorzano-Restrepo C; Gonzalez J; Olmos M; Godfrey K; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011161. PubMed ID: 27455163
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of stromelysin-3 in basal cell carcinomas.
Majmudar G; Nelson BR; Jensen TC; Voorhees JJ; Johnson TM
Mol Carcinog; 1994 Jan; 9(1):17-23. PubMed ID: 8297480
[TBL] [Abstract][Full Text] [Related]
6. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up-regulated by transforming growth factor-beta1 in keratinocytes.
Ahokas K; Lohi J; Illman SA; Llano E; Elomaa O; Impola U; Karjalainen-Lindsberg ML; Saarialho-Kere U
Lab Invest; 2003 Dec; 83(12):1887-99. PubMed ID: 14691307
[TBL] [Abstract][Full Text] [Related]
8. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.
Dumas V; Kanitakis J; Charvat S; Euvrard S; Faure M; Claudy A
Anticancer Res; 1999; 19(4B):2929-38. PubMed ID: 10652575
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
Roberts MR; Asgari MM; Toland AE
Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study.
Venables ZC; Nijsten T; Wong KF; Autier P; Broggio J; Deas A; Harwood CA; Hollestein LM; Langan SM; Morgan E; Proby CM; Rashbass J; Leigh IM
Br J Dermatol; 2019 Sep; 181(3):474-482. PubMed ID: 30864158
[TBL] [Abstract][Full Text] [Related]
12. Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion.
Vosseler S; Lederle W; Airola K; Obermueller E; Fusenig NE; Mueller MM
Int J Cancer; 2009 Nov; 125(10):2296-306. PubMed ID: 19610062
[TBL] [Abstract][Full Text] [Related]
13. The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma.
Piipponen M; Riihilä P; Nissinen L; Kähäri VM
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572732
[TBL] [Abstract][Full Text] [Related]
14. Complement factor I upregulates expression of matrix metalloproteinase-13 and -2 and promotes invasion of cutaneous squamous carcinoma cells.
Rahmati Nezhad P; Riihilä P; Piipponen M; Kallajoki M; Meri S; Nissinen L; Kähäri VM
Exp Dermatol; 2021 Nov; 30(11):1631-1641. PubMed ID: 33813765
[TBL] [Abstract][Full Text] [Related]
15. Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults.
Dinnes J; Deeks JJ; Chuchu N; Saleh D; Bayliss SE; Takwoingi Y; Davenport C; Patel L; Matin RN; O'Sullivan C; Patalay R; Williams HC;
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013191. PubMed ID: 30521687
[TBL] [Abstract][Full Text] [Related]
16. H-Ras activation and fibroblast-induced TGF-β signaling promote laminin-332 accumulation and invasion in cutaneous squamous cell carcinoma.
Siljamäki E; Rappu P; Riihilä P; Nissinen L; Kähäri VM; Heino J
Matrix Biol; 2020 May; 87():26-47. PubMed ID: 31655292
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of tissue inhibitor of metalloproteinases-2 by cutaneous squamous and basal cell carcinomas.
Wagner SN; Ockenfels HM; Wagner C; Soyer HP; Goos M
J Invest Dermatol; 1996 Feb; 106(2):321-6. PubMed ID: 8601735
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the interplay between senescent dermal fibroblasts and cutaneous squamous cell carcinoma cell lines at different stages of tumorigenesis.
Toutfaire M; Dumortier E; Fattaccioli A; Van Steenbrugge M; Proby CM; Debacq-Chainiaux F
Int J Biochem Cell Biol; 2018 May; 98():113-126. PubMed ID: 29550586
[TBL] [Abstract][Full Text] [Related]
19. Methylation status, mRNA and protein expression of the SMAD4 gene in patients with non-melanocytic skin cancers.
Gürsel Ürün Y; Budak M; Usturalı Keskin E
Mol Biol Rep; 2023 Sep; 50(9):7295-7304. PubMed ID: 37428273
[TBL] [Abstract][Full Text] [Related]
20. Current Perspectives on the Role of Matrix Metalloproteinases in the Pathogenesis of Basal Cell Carcinoma.
Tampa M; Georgescu SR; Mitran MI; Mitran CI; Matei C; Caruntu A; Scheau C; Nicolae I; Matei A; Caruntu C; Constantin C; Neagu M
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
